⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
United States Multiple Myeloma Market Report: Growth Drivers and Challenges 2025-2033
globenewswire.com
ABBV
JNJ
PFE
BMY
Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes
prnewswire.com
NVS
LLY
AZN
MRK
ABBV
BMED
MGNX
Disease-Modifying Therapies Market to Surpass USD 112.6 Billion by 2033 as Biologic Innovation Redefines Long-Term Disease Control
prnewswire.com
JNJ
ABBV
AZN
GSK
AMGN
UCB’s Bimzelx Continues to Shift Biologic Treatment Patterns in Hidradenitis Suppurativa as Demand for Innovation Grows, According to Spherix Global Insights
globenewswire.com
ABBV
INCY
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM
BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator
prnewswire.com
JNJ
ABBV
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
businesswire.com
RPRX
ABBV
NVS
ZURA
INCY
AZN
Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders
prnewswire.com
JNJ
ABBV
GOOG
META
UBER
GNPX
Uterine Fibroid Drugs Market Set to Reach US$ 12.8 Billion by 2035 | Astute Analytica
globenewswire.com
ABBV
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
prnewswire.com
RDHL
ABBV
GILD